Nkarta to Participate at Upcoming Investor Conference

Rhea-AI Summary

Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company focused on engineered NK cell therapies for cancer, will present at the Cowen 3rd Annual Oncology Innovation Summit on June 2, 2022, at 11:00 a.m. ET. The event will feature a fireside chat, and a simultaneous webcast will be accessible on Nkarta's website. A replay will be available for four weeks following the event. Nkarta is advancing off-the-shelf NK cell therapies utilizing advanced technologies to enhance anti-tumor activity and improve patient access.

News Market Reaction – NKTX

+6.49%

+6.49% Session move

In the trading session that priced this news, NKTX gained 6.49%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at an upcoming investor conference:

Cowen 3rd Annual Oncology Innovation Summit
June 2, 2022
11:00 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com

FAQ

When is Nkarta presenting at the Cowen 3rd Annual Oncology Innovation Summit?

Nkarta will present on June 2, 2022, at 11:00 a.m. ET.

Where can I watch Nkarta's presentation at the investor conference?

The presentation will be available via a webcast on Nkarta's website.

What is the focus of Nkarta, Inc.?

Nkarta focuses on developing engineered NK cell therapies for cancer treatment.

How long will the replay of Nkarta's conference presentation be available?

The replay will be available for approximately four weeks after the event.

What technologies does Nkarta use in its cell therapies?

Nkarta utilizes a cryopreservation platform and CRISPR-based genome engineering for its NK cell therapies.